Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross-over trial

Food and Chemical Toxicology

Volumn 56, Issue , 2013, Pages 178-183

  Valentová, Kateřina ^a   Vidlář, Aleš ^b   Zatloukalová, Martina ^a   Stuchlík, Milan ^c   Vacek, Jan ^a   šimánek, Vilím ^a   Ulrichová, Jitka ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^c AGRA GROUP as ^*  (Czech Republic)

Author keywords

Erythrocyte protection; Flavonolignan; Intervention trial; L Arginine; Oxidative stress

Indexed keywords

ARGININE; CATALASE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MALONALDEHYDE; SILIBININ; SILYMARIN; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BEVERAGE; BIOSAFETY; BLOOD ANALYSIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; EX VIVO STUDY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; MEMBRANE BINDING; NORMAL HUMAN; OXIDATIVE STRESS; PILOT STUDY; URINALYSIS;

ADULT; ANTIOXIDANTS; ARGININE; BEVERAGES; CATALASE; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; ERYTHROCYTES; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; INTERVENTION STUDIES; MALE; MALONDIALDEHYDE; MIDDLE AGED; PILOT PROJECTS; SILYMARIN; SUPEROXIDE DISMUTASE;

EID: 84875267110     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.02.023     Document Type: Article

References (45)

1. Abenavoli L., Capasso R., Milic N., Capasso F. Milk thistle in liver diseases: past, present, future. Phytother. Res. 2010, 24:1423-1432.
2. Absolom D.R., Zingg W., Thomson C., Policova Z., Vanoss C.J., Neumann A.W. Erythrocyte adhesion to polymer surfaces. J. Colloid Interf. Sci. 1985, 104:51-59.
3. Alvarez-Suarez J.M., Giampieri F., Gonzalez-Paramas A.M., Damiani E., Astolfi P., Martinez-Sanchez G., Bompadre S., Quiles J.L., Santos-Buelga C., Battino M. Phenolics from monofloral honeys protect human erythrocyte membranes against oxidative damage. Food Chem. Toxicol. 2012, 50:1508-1516.
4. Arranz S., Chiva-Blanch G., Valderas-Martinez P., Medina-Remon A., Lamuela-Raventos R.M., Estruch R. Wine, beer, alcohol and polyphenols on cardiovascular disease and cancer. Nutrients 2012, 4:759-781.
5. Bescos R., Sureda A., Tur J.A., Pons A. The effect of nitric-oxide-related supplements on human performance. Sports Med. 2012, 42:99-117.
6. BouŠová I., Skálová L. Inhibition and induction of glutathione S-transferases by flavonoids: possible pharmacological and toxicological consequences. Drug Metab. Rev. 2012, 44:267-286.
7. BouŠová I., Hájek J., DrŠata J., Skálová L. Naturally occurring flavonoids as inhibitors of purified cytosolic glutathione S-transferase. Xenobiotica 2012, 42:872-879.
8. Cao H., Xie Y.X., Chen X.Q., Xiao J.B. Human serum albumin masks antioxidant potential of dietary polyphenols. Free Radical Biol. Med. 2012, 53. S99.
9. Deep G., Oberlies N.H., Kroll D.J., Agarwal R. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells. Int. J. Cancer 2008, 123:41-50.
10. Deep G., Raina K., Singh R.P., Oberlies N.H., Kroll D.J., Agarwal R. Isosilibinin inhibits advanced human prostate cancer growth in athymic nude mice: comparison with silymarin and silibinin. Int. J. Cancer 2008, 123:2750-2758.
11. Deep G., Gangar S.C., Rajamanickam S., Raina K., Gu M., Agarwal C., Oberlies N.H., Agarwal R. Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF-VEGFR signaling. PLoS One 2012, 7:e34630.
12. Dominici S., Paolicchi A., Corti A., Maellaro E., Pompella A. Prooxidant reactions promoted by soluble and cell-bound gamma-glutamyltransferase activity. Method. Enzymol. 2005, 401:484-501.
13. Duchnowicz P., Bors M., Podsedek A., Koter-Michalak M., Broncel M. Effect of polyphenols extracts from Brassica vegetables on erythrocyte membranes (in vitro study). Environ. Toxicol. Pharmacol. 2012, 34:783-790.
14. El-Kamary S.S., Shardell M.D., Abdel-Hamid M., Ismail S., El-Ateek M., Metwally M., Mikhail N., Hashem M., Mousa A., Aboul-Fotouh A., El-Kassas M., Esmat G., Strickland G.T. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Phytomedicine 2009, 16:391-400.
15. Flaig T.W., Glode M., Gustafson D., Van Bokhoven A., Tao Y., Wilson S., Su L.J., Li Y., Harrison G., Agarwal R., Crawford E.D., Lucia M.S., Pollak M. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer. Prostate 2010, 70:848-855.
16. GaŽák R., Walterová D., Křen V. Silybin and silymarin - new and emerging applications in medicine. Curr. Med. Chem. 2007, 14:315-338.
17. GaŽák R., Valentová K., Fuksová K., Marhol P., Kuzma M., Medina M.A., Oborná I., Ulrichová J., Křen V. Synthesis and antiangiogenic activity of new silybin galloyl esters. J. Med. Chem. 2011, 54:7397-7407.
18. Ginsburg I., Kohen R., Koren E. Quantifying oxidant-scavenging ability of blood. New Engl. J. Med. 2011, 364:883-885.
19. Hendrich A.B. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Acta Pharm. Sin. 2006, 27:27-40.
20. Jančová P., Anzenbacherová E., PapouŠková B., Lemr K., LuŽná P., Veinlichová A., Anzenbacher P., Šimánek V. Silybin is metabolized by cytochrome P450 2C8 in vitro. Drug Metab. Dispos. 2007, 35:2035-2039.
21. Kidd P., Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern. Med. Rev. 2005, 10:193-203.
22. Koren E., Kohen R., Ginsburg I. Polyphenols enhance total oxidant-scavenging capacities of human blood by binding to red blood cells. Exp. Biol. Med. (Maywood) 2010, 235:689-699.
23. Kosina P., Křen V., Gebhardt R., Grambal F., Ulrichová J., Walterová D. Antioxidant properties of silybin glycosides. Phytother. Res. 2002, 16(Suppl. 1):S33-S39.
24. Krecman V., Skottova N., Walterova D., Ulrichova J., Simanek V. Silymarin inhibits the development of diet-induced hypercholesterolemia in rats. Planta Med. 1998, 64:138-142.
25. Křen V., Walterová D. Silybin and silymarin - new effects and applications. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Republic 2005, 149:29-41.
26. Křen V., Ulrichová J., Kosina P., Stevenson D., Sedmera P., Přikrylová V., Halada P., Šimánek V. Chemoenzymatic preparation of silybin beta-glucuronides and their biological evaluation. Drug Metab. Dispos. 2000, 28:1513-1517.
27. Kroll D.J., Shaw H.S., Oberlies N.H. Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies. Integr. Cancer Ther. 2007, 6:110-119.
28. Liu C.F., Zhou W.N., Fang N.Y. Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies. Int. J. Clin. Pract. 2012, 66:692-698.
29. Mengs U., Pohl R.T., Mitchell T. Legalon SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning. Curr. Pharm. Biotechnol. 2012, 13:1964-1970.
30. Morazzoni P., Montalbetti A., Malandrino S., Pifferi G. Comparative pharmacokinetics of silipide and silymarin in rats. Eur. J. Drug Metab. Pharm. 1993, 18:289-297.
31. Pompella A., Corti A., Paolicchi A., Giommarelli C., Zunino F. Gamma-glutamyltransferase, redox regulation and cancer drug resistance. Curr. Opin. Pharmacol. 2007, 7:360-366.
32. Šimánek V., Křen V., Ulrichová J., Vičar J., Cvak L. Silymarin: what is in the name...? An appeal for a change of editorial policy. Hepatology 2000, 32:442-444.
33. Skottova N., Krecman V. Silymarin as a potential hypocholesterolaemic drug. Physiol Res. 1998, 47:1-7.
34. Škottová N., Kazdová L., Oliyarnyk O., Večeřa R., Sobolová L., Ulrichová J. Phenolics-rich extracts from Silybum marianum and Prunella vulgaris reduce a high-sucrose diet induced oxidative stress in hereditary hypertriglyceridemic rats. Pharmacol. Res. 2004, 50:123-130.
35. Stothers L., Laher I., Christ G.T. A review of the l-arginine-nitric oxide-guanylate cyclase pathway as a mediator of lower urinary tract physiology and symptoms. Can. J. Urol. 2003, 10:1971-1980.
36. Stuchlík, M., Kopenec, J., 2008a. Beer and beer based beverages and method of modification of polyphenols and silicon content in these beverages, EP 2369947 (Priority 23.12.08).
37. Stuchlík, M., Kopenec, J., 2008b. Composition of flavanolignans and aminoacids with improved water solubility, EP 2307405 (Priority 26.6.08).
38. Tedesco D., Tava A., Galletti S., Tameni M., Varisco G., Costa A., Steidler S. Effects of silymarin, a natural hepatoprotector, in periparturient dairy cows. J. Dairy Sci. 2004, 87:2239-2247.
39. Valentová K., Stejskal D., Bartek J., Dvořáčková S., Křen V., Ulrichová J., Šimánek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food Chem. Toxicol. 2008, 46:1006-1013.
40. Vidlář A., Vostálová J., Ulrichová J., Študent V., Krajíček M., Vrbková J., Šimánek V. The safety and efficacy of a silymarin and selenium combination in men after radical prostatectomy - a six month placebo-controlled double-blind clinical trial. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Republic 2010, 154:239-244.
41. Voinovich D., Perissutti B., Grassi M., Passerini N., Bigotto A. Solid state mechanochemical activation of Silybum marianum dry extract with betacyclodextrins: characterization and bioavailability of the coground systems. J. Pharm. Sci. 2009, 98:4119-4129.
42. Wellington K., Jarvis B. Silymarin: a review of its clinical properties in the management of hepatic disorders. BioDrugs 2001, 15:465-489.
43. Wen Z., Dumas T.E., Schrieber S.J., Hawke R.L., Fried M.W., Smith P.C. Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract. Drug Metab. Dispos. 2008, 36:65-72.
44. Whitfield J.B. Gamma glutamyl transferase. Crit. Rev. Clin. Lab. Sci. 2001, 38:263-355.
45. Zatloukalová M., Křen V., GaŽák R., Kubala M., Trouillas P., Ulrichová J., Vacek J. Electrochemical investigation of flavonolignans and study of their interactions with DNA in the presence of Cu(II). Bioelectrochemistry 2011, 82:117-124.